Literature DB >> 28094585

Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect.

Jae Yeun Lee1, Joon Mo Kim1, In Tae Kim1, Chung Kwon Yoo2, Yu Sam Won3, Jung Hoon Kim4, Hyun Seok Kwon5, Ki Ho Park6.   

Abstract

AIMS: To investigate the association between plasma homocysteine levels and glaucomatous retinal nerve fiber layer (RNFL) defect in South Korean population.
MATERIALS AND METHODS: This retrospective cross-sectional study included subjects who underwent screening at Kangbuk Samsung Hospital Health Screening Center between August 2012 and July 2013. Subjects underwent physical examination and provided samples for laboratory analysis of homocysteine. Subjects were divided equally into four quartiles (Qs) based on plasma homocysteine level. Digital fundus photographs of both eyes were obtained. Determination of glaucomatous disc appearance was based on criteria set forth by the International Society of Geographical and Epidemiological Ophthalmology and based on the appearance of the RNFL and optic disc. Multivariate logistic regression models were used to define elevated glaucoma risk with P < 0.2 on univariate analysis.
RESULTS: A total of 78,049 subjects were included; 76,093 subjects were male, and 1956 subjects were female. When analyzed by gender, the mean homocysteine level in the male group with glaucomatous RNFL defects (11.05 ± 3.80 µmol/L) was higher than those without RNFL defects (10.81 ± 4.12 µmol/L (P = 0.000, χ2 test). Upon multifactorial logistic regression analysis adjusted for age, gender, creatinine, diabetes mellitus, hypertension, and hyperlipidemia, glaucomatous RNFL defects had a significant correlation with plasma homocysteine level. Based on the Q2 level, the odds ratio (OR) of Q3 was 1.267, while the OR of Q4 was 1.285 (95% CI = 1.067-1.505, 1.081-1.529, respectively, P for trend = 0.001).
CONCLUSION: Our results suggest that homocysteine level is associated with the presence of glaucomatous RNFL defects.

Entities:  

Keywords:  Disc hemorrhage; RNFL defect; homocysteine; intraocular pressure; open-angle glaucoma

Mesh:

Substances:

Year:  2017        PMID: 28094585     DOI: 10.1080/02713683.2016.1257728

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Effect of long-term chronic hyperhomocysteinemia on retinal structure and function in the cystathionine-β-synthase mutant mouse.

Authors:  Haiyan Xiao; Jing Wang; Shannon R Barwick; Yisang Yoon; Sylvia B Smith
Journal:  Exp Eye Res       Date:  2021-12-11       Impact factor: 3.770

2.  Sensitized heat shock protein 27 induces retinal ganglion cells apoptosis in rat glaucoma model.

Authors:  Wei Zhao; Le Dai; Xiao-Ting Xi; Qian-Bo Chen; Mei-Xia An; Yan Li
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

3.  Hyperhomocysteinemia-induced death of retinal ganglion cells: The role of Müller glial cells and NRF2.

Authors:  Soumya Navneet; Jing Zhao; Jing Wang; Barbara Mysona; Shannon Barwick; Navneet Ammal Kaidery; Alan Saul; Ismail Kaddour-Djebbar; Wendy B Bollag; Bobby Thomas; Kathryn E Bollinger; Sylvia B Smith
Journal:  Redox Biol       Date:  2019-04-11       Impact factor: 11.799

4.  A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes.

Authors:  Doreen Schmidl; Kinga Howorka; Stephan Szegedi; Kristina Stjepanek; Stefan Puchner; Ahmed Bata; Ulrike Scheschy; Gerold Aschinger; René M Werkmeister; Leopold Schmetterer; Gerhard Garhofer
Journal:  Mol Vis       Date:  2020-04-24       Impact factor: 2.367

5.  MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate.

Authors:  Qi Zhang; Jinran Lin; Zhenghua Zhang; Ling Han; Qiong Huang; Jie Zhu; Bing Wang; Xu Fang; Zhizhong Zheng; Nikhil Yawalkar; Jun Liang; Kexiang Yan
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.